Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cipla
Merck
Fish and Richardson
Novartis
Cantor Fitzgerald
Accenture
Citi
Farmers Insurance
Baxter

Generated: February 17, 2018

DrugPatentWatch Database Preview

LOPROX Drug Profile

« Back to Dashboard

Which patents cover Loprox, and what generic alternatives are available?

Loprox is a drug marketed by Medimetriks Pharms and Medicis and is included in three NDAs.

The generic ingredient in LOPROX is ciclopirox. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.

US Patents and Regulatory Information for LOPROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medimetriks Pharms LOPROX ciclopirox CREAM;TOPICAL 018748-001 Dec 30, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 AT RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medimetriks Pharms LOPROX ciclopirox SUSPENSION;TOPICAL 019824-001 Dec 30, 1988 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LOPROX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medimetriks Pharms LOPROX ciclopirox SUSPENSION;TOPICAL 019824-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Medimetriks Pharms LOPROX ciclopirox CREAM;TOPICAL 018748-001 Dec 30, 1982 ➤ Sign Up ➤ Sign Up
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 ➤ Sign Up ➤ Sign Up
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for LOPROX
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Gel 0.77% ➤ Subscribe 5/10/2006

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
US Army
Cantor Fitzgerald
Julphar
Deloitte
QuintilesIMS
McKinsey
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot